Results 11 to 20 of about 95,684 (265)

Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France [PDF]

Emerging Infectious Diseases, 2008
The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 β-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000–2005. Because this strain was not detected in food
Svetlana Egorova, Mohammed Timinouni, Marie Demartin, Sophie A. Granier, Jean M. Whichard, Vartul Sangal, Laëtitia Fabre, Aurélia Delauné, Maria Pardos, Yves Millemann, Emmanuelle Espié, Mark Achtman, Patrick A.D. Grimont, François-Xavier Weill   +13 more
doaj   +2 more sources

Ceftriaxone-induced Agranulocytosis [PDF]

, 2021
Ceftriaxone is a widely used antibiotic regarded as safe and effective. Drug-induced agranulocytosis is a life-threatening adverse reaction and few reports related to ceftriaxone were found in a review of the literature.
Teixeira, Carolina, Garça, Magda, Cota, Pedro, Couto, Lénio, Santos, Maria Beatriz, Valadão, Ivone, Goulart, André   +6 more
core   +1 more source

Penicillin-Susceptible Streptococcus pneumoniae Meningitis in Adults: Does the Ceftriaxone Dosing Matter? [PDF]

, 2023
The recommended empiric ceftriaxone dosing regimen for acute bacterial meningitis in adults is 2 g every 12 h. After penicillin-susceptible Streptococcus pneumoniae is isolated as a causative microorganism, the ceftriaxone dose may be continued or ...
Carlo Casanova, Aaron J. Tande, Baldan, Rossella, Endimiani, Andrea, Fischer, Urs, Sendi, Parham, Tande, Aaron J, Casanova, Carlo, Stephen L. Leib, Samuel Raemy, Erin Barreto, Andrea Endimiani, Urs Fischer, Raemy, Samuel, Parham Sendi, Rossella Baldan, Leib, Stephen L, Barreto, Erin   +17 more
core   +2 more sources

Perioperative infection prophylaxis and risk factor impact in colon surgery [PDF]

, 2000
Background: A prospective observational study was undertaken in 2,481 patients undergoing elective colon resection in 114 German centers to identify optimal drug and dosing modalities and risk factors for postoperative infection.
Rau, H. G., Zimmermann, A., Lachmann, A., Kohler, L., Mittelkotter, U., Kullmann, K. H., H.G. Rau, A. Lachmann, A. Zimmermann, K.H. Kullmann, U. Mittelkötter, L. Köhler   +11 more
core   +1 more source

A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis. [PDF]

, 2009
OBJECTIVES: To review evidence supporting use of fluoroquinolones as first line agents over other antibiotics for treating typhoid and paratyphoid fever (enteric fever). DESIGN: Meta-analysis of randomised controlled trials.
Thaver, D, Critchley, Julia, Azmatullah, Asma, Bhutta, Zulfiqar Ahmed, Critchley, J, Zaidi, AK, Zaidi, Anita K. M., Madni, Syed Ali, Azmatullah, A, Madni, SA, Bhutta, ZA, Thaver, Durrane   +11 more
core   +1 more source

Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin

The Turkish Journal of Pediatrics, 2016
Drug-induced hemolytic anemia is an immune-mediated phenomenon that leads to the destruction of red blood cells. Here, we present a case of life-threatening ceftriaxone-induced hemolytic anemia (CIHA) in a previously healthy 3-year-old girl.
Aysel Vehapoğlu, Nilüfer Göknar, Rümeysa Tuna, Fatma Betül Çakır   +3 more
doaj   +1 more source

Minimum inhibitory concentration (MIC) of Ceftriaxone and Azithromycin for blood culture isolates of Salmonella enterica spp.

Journal of Infection in Developing Countries, 2021
Introduction: Enteric fever caused by Salmonella enterica continues to be a major public health problem worldwide. In the last decade, ceftriaxone and azithromycin have become the drugs of choice for treating enteric fever caused by Nalidixic acid ...
Rashmi Shankar Kokare, Anurag Kumar Bari, Joanna Valanie Pereira, Kinjal Patel, Aruna Poojary   +4 more
doaj   +1 more source

Tolerance to Ceftriaxone in Neisseria gonorrhoeae: Rapid Induction in WHO P Reference Strain and Detection in Clinical Isolates

Antibiotics, 2022
In addition to antimicrobial resistance, bacteria contain other mechanisms to survive antibiotic exposure such as tolerance, defined as the ability to slow metabolism by the extension of the lag phase without altering antimicrobial susceptibility.
Margaux Balduck, Jolein Gyonne Elise Laumen, Saïd Abdellati, Irith De Baetselier, Tessa de Block, Sheeba Santhini Manoharan-Basil, Chris Kenyon   +6 more
doaj   +1 more source

Reliability of Genetic Alterations in Predicting Ceftriaxone Resistance in Neisseria gonorrhoeae Globally

Microbiology Spectrum, 2022
Antimicrobial resistance in N. gonorrhoeae is increasing globally, and ceftriaxone is the recommended treatment for empirical therapy in most settings. Developing molecular assays to detect decreased ceftriaxone susceptibility is critical.
Eric Yu Lin, Paul C. Adamson, Sung-min Ha, Jeffrey D. Klausner   +3 more
doaj   +1 more source

Observation of substrate diffusion and ligand binding in enzyme crystals using high-repetition-rate mix-and-inject serial crystallography

IUCrJ, 2021
Here, we illustrate what happens inside the catalytic cleft of an enzyme when substrate or ligand binds on single-millisecond timescales. The initial phase of the enzymatic cycle is observed with near-atomic resolution using the most advanced X-ray ...
Suraj Pandey, George Calvey, Andrea M. Katz, Tek Narsingh Malla, Faisal H. M. Koua, Jose M. Martin-Garcia, Ishwor Poudyal, Jay-How Yang, Mohammad Vakili, Oleksandr Yefanov, Kara A. Zielinski, Sasa Bajt, Salah Awel, Katarina Doerner, Matthias Frank, Luca Gelisio, Rebecca Jernigan, Henry Kirkwood, Marco Kloos, Jayanath Koliyadu, Valerio Mariani, Mitchell D. Miller, Grant Mills, Garrett Nelson, Jose L. Olmos Jr, Alireza Sadri, Tokushi Sato, Alexandra Tolstikova, Weijun Xu, Abbas Ourmazd, John C. H. Spence, Peter Schwander, Anton Barty, Henry N. Chapman, Petra Fromme, Adrian P. Mancuso, George N. Phillips Jr, Richard Bean, Lois Pollack, Marius Schmidt   +39 more
doaj   +1 more source